KLOW

weak data

Also seen as: KLOW Blend, GHK-Cu + BPC-157 + TB-500 + KPV

The Dose Guy’s verdict

Oct 27, 2026
0 sources

KLOW is GLOW with KPV added, and the appeal is GLOW’s appeal stretched to four peptides people already like, mixed into one vial. The catch is that nobody has ever studied the mix, so the case rests entirely on the parts, and the ratios are the vendor’s recipe, not anyone’s dose finding. Pick KLOW over GLOW only if inflammation or a cranky gut is part of why you’re running it. If skin and recovery are the whole job, GLOW does that with one fewer unknown.

Would I take it?Maybe, if you want the gut angle.

What it is

A blend of four peptides in one vial. Three of them are GLOW: GHK-Cu, the copper peptide for skin, collagen, and hair; BPC-157, the gut-derived repair peptide people pin for tendons and stomach trouble; and TB-500, the thymosin beta-4 fragment run for tissue repair and mobility. The fourth is KPV, a three-amino-acid tail clipped off alpha-MSH. It keeps that hormone’s anti-inflammatory signal, calming the inflammatory switch inside immune and gut-lining cells, without the part that tans you.

So the pitch is GLOW’s skin-and-repair stack with an inflammation brake bolted on. In practice GHK-Cu is most of the vial by weight, which makes KLOW a copper peptide shot with three repair and anti-inflammatory riders. Compared with GLOW, the only real question is whether you want KPV along for the ride.

What the research shows

No human trials. Zero. Everything below is animal or in-vitro work. Read it as “interesting,” not “evidence it works in you.”

There is no KLOW literature. Every bit of evidence lives on the individual peptides’ pages, and the blend itself has never been put in a person, an animal, or a dish:

No human trial of KLOW exists, randomized or otherwise, and no measured human outcome for the blend, for efficacy or for safety.as of Oct 2026

No animal or cell study of the combined formulation exists. No published study has checked whether the four peptides help, ignore, or get in each other’s way when mixed.as of Oct 2026

No studied human dose, route, or schedule exists for the blend. Every number in the protocol below is community practice built around the vendor’s ratio.as of Oct 2026

Realistic protocols

The common recipe is GLOW’s ratio plus KPV: 50 mg GHK-Cu, 10 mg BPC-157, 10 mg TB-500, and 10 mg KPV per vial. Check your label and your COA, because shops vary, and every dose below assumes that recipe. People run KLOW as a 4 to 8 week block, subcutaneous, once daily, then take a few weeks off and judge the result in the mirror. GLOW users often pin two to three times a week instead; KLOW practice runs smaller daily shots dosed by the copper, and nothing studied favors either rhythm.

Dose it by the copper. Because the ratio is fixed, you can’t push the BPC-157 or KPV without pushing the GHK-Cu, and GHK-Cu is the part that stings. Reconstitute the vial with 3 mL of bacteriostatic water. At that mix, 10 units on an insulin syringe lands around 1.7 mg of GHK-Cu and roughly 330 mcg each of the other three, which is a normal dose of every component. Start lower, around 5 units, for the first few days to see how your skin takes the copper. If 10 units feels fine and you’re seeing results, that is your dose for the whole block; there’s nothing to climb toward. If the sting is the limit, more water in the vial and slower pushes help more than smaller doses do.

Living on it is easy. No food timing, no alcohol rule beyond the obvious one that drinking works against the inflammation you’re trying to calm. If the gut is the reason you picked KLOW, standalone KPV taken by mouth puts it right where the problem is, and plenty of people run that instead of a four-way pin.

First days~5 unitsHalf dose to see how your skin handles the copper sting.

The block~10 units dailyAbout 1.7 mg GHK-Cu plus ~330 mcg each of the rest, on a 3 mL mix.

Length4–8 weeksThen a few weeks off and an honest look in the mirror.

Gut onlyKPV aloneIf the gut is the whole point, run KPV by itself instead of the blend.

Side effects

Four peptides means four sets of sides, and a fixed ratio means you can’t tell which one is talking:

commonStinging, redness, and a sore lump at the injection site, almost always the GHK-Cu. More water in the vial and rotating sites fixes most of it.

anecdotalTiredness, mild nausea, or a lightheaded spell after the shot, reported by some on BPC-157 and TB-500 blends and usually gone in the first week.

monitorInjection-site redness that spreads or lingers past a few days, or gut symptoms that get worse instead of better. In a blend you can’t isolate the culprit, so stop, and if you want to try again, reintroduce the parts one at a time.

unknownBPC-157 and TB-500 both push blood-vessel and tissue growth. With zero human safety data on the blend, skip it if you have an active cancer or a history of one.